ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia; Company to Provide Regulatory, Sales, and Platform Updates at Investor Day including:

Media coverage

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia; Company to Provide Regulatory, Sales, and Platform Updates at Investor Day including:
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	15/04/25
  Persons	Carlos Cordon-Cardo,

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
  Media name/outlet	Business Wire
  Country/Territory	United States
  Date	15/04/25
  URL	ct.moreover.com/?a=56498471874&p=1gw&v=1&x=qLAxYTjCQXL-csBpmuu3LQ
  Persons	Carlos Cordon-Cardo,

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
  Media name/outlet	ADVFN UK
  Country/Territory	United Kingdom
  Date	15/04/25
  URL	ct.moreover.com/?a=56498426175&p=1gw&v=1&x=ZxrtoFdd3zxxS6AasDt73Q
  Persons	Carlos Cordon-Cardo,

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia | IBRX Stock News
  Media name/outlet	StockTitan.net
  Country/Territory	United States
  Date	15/04/25
  URL	ct.moreover.com/?a=56498427335&p=1gw&v=1&x=alzuHxM129iW7DpaQQiMDg
  Persons	Carlos Cordon-Cardo,

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
  Media name/outlet	Yahoo! Finance
  Country/Territory	United States
  Date	15/04/25
  URL	ct.moreover.com/?a=56498472909&p=1gw&v=1&x=hDTfoIYlTusMm5t0zJAPxg
  Persons	Carlos Cordon-Cardo,

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
  Media name/outlet	APNews.com
  Country/Territory	United States
  Date	15/04/25
  URL	ct.moreover.com/?a=56498452348&p=1gw&v=1&x=1tWLD7MCZl4hel5yWkprPQ
  Persons	Carlos Cordon-Cardo,

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
  Media name/outlet	MarketScreener.com
  Country/Territory	United States
  Date	15/04/25
  URL	ct.moreover.com/?a=56498605643&p=1gw&v=1&x=eXqONMm5kOiv4wsMS_guMw
  Persons	Carlos Cordon-Cardo,

• Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA(TM) to Treat Lymphopenia
  Media name/outlet	Stockwatch
  Country/Territory	Canada
  Date	15/04/25
  URL	ct.moreover.com/?a=56498499576&p=1gw&v=1&x=sSI0-5TKsiNM-MUYIZzTrA
  Persons	Carlos Cordon-Cardo,